HYFT Key Statistics, Chart & Performance
The current stock price of HYFT is 2.3 USD. In the past month the price increased by 32.95%.
HYFT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to HYFT.
HYFT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HYFT. While HYFT seems to be doing ok healthwise, there are quite some concerns on its profitability.
HYFT Financial Highlights
Over the last trailing twelve months HYFT reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 57.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -114.31% | ||
| ROE | -168.52% | ||
| Debt/Equity | 0.18 |
HYFT Forecast & Estimates
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 77.39% is expected in the next year compared to the current price of 2.3.
For the next year, analysts expect an EPS growth of 38.8% and a revenue growth -33.14% for HYFT
HYFT Ownership
HYFT Latest News, Press Relases and Analysis
About HYFT
Company Profile
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Company Info
MINDWALK HOLDINGS CORP
Industrious, 823 Congress Ave, Suite 300
Austin TEXAS US
Employees: 102
Phone: 16048060626
MINDWALK HOLDINGS CORP / HYFT FAQ
What does HYFT do?
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
What is the current price of HYFT stock?
The current stock price of HYFT is 2.3 USD. The price increased by 13.3% in the last trading session.
Does HYFT stock pay dividends?
HYFT does not pay a dividend.
What is the ChartMill technical and fundamental rating of HYFT stock?
HYFT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting HYFT stock to perform?
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 77.39% is expected in the next year compared to the current price of 2.3.
What is the market capitalization of HYFT stock?
MINDWALK HOLDINGS CORP (HYFT) has a market capitalization of 106.14M USD. This makes HYFT a Micro Cap stock.
Can you provide the ownership details for HYFT stock?
You can find the ownership structure of MINDWALK HOLDINGS CORP (HYFT) on the Ownership tab.